Celiac Disease Found Not to Increase Cancer-Related Death
the Cancer Therapy Advisor take:
According to a new study published in the journal Gut, patients with celiac disease not more likely than the general population to die from cancer or heart disease within 10 years of their celiac disease diagnosis.
In contrast, patients with celiac disease were had a slightly lower risk than the general population for dying from heart disease. For the study, researchers at The University of Nottingham in Nottingham, United Kingdom, sought to investigate whether celiac disease increases a person's risk for dying from certain diseases, as previous studies have demonstrated mixed results.
Researchers identified about 11,000 patients with celiac disease and over 100,000 patients with similar characteristics without celiac disease from a database of primary care records. They found a similar mortality rate among both groups.
The researchers found no overall difference in mortality rates caused by cancer, digestive disease, or respiratory disease. Patients with celiac disease were a bit less likely to die from heart disease, but were very slightly more likely to die as a result of non-Hodgkin's lymphoma. The findings of this large study suggest that celiac disease does not increase a patient's risk of death.
Patients with celiac disease not more likely than the general population to die from cancer.
By 10 years after a diagnosis of celiac disease, people with the condition are no more likely to die from cancer or cardiovascular disease than the general population, according to a new study. People with celiac disease were, in fact, slightly less likely to die of cardiovascular disease than others in the new study.
When people with celiac disease, a hereditary condition, eat gluten from rye, wheat and barley, their immune systems respond by damaging the small intestine. As many as two million Americans may have the condition, according to the U.S. Department of Health and Human Services, but most do not know it. Previous studies looking at the influence of celiac disease on risk of dying from various causes have been mixed, the study authors write in the journal Gut.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing
- Investigational Antiandrogen Drug Delays Metastasis in CRPC
- Tivozanib Offers Superior Outcomes in Refractory Metastatic Renal Cell Carcinoma
- First-Line Pembrolizumab Shows Promise in Non-Clear Cell RCC
- Early Tumor Shrinkage With Cabozantinib Improves Survival in Renal Cell Carcinoma
- Combo Superior to Sunitinib in Advanced Renal Cell Carcinoma
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed